Leukotriene C4



Compound IDCDAMM02522
Common nameLeukotriene C4
IUPAC name6-[2-[(4-amino-4-carboxybutanoyl)amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
Molecular formulaC30H47N3O9S

Experimental data

Retention time26.17
Adduct[M+H]+
Actual mz626.317
Theoretical mz626.31
Error11.37
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.6136

Identifiers and class information

Inchi keyGWNVDXQDILPJIG-NXOLIXFESA-N
SmilesO=C(O)CNC(=O)C(NC(=O)CCC(N)C(=O)O)CSC(C=CC=CC=CCC=CCCCCC)C(O)CCCC(=O)O
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)3
Number of non-conjugated amide groups (#amide)2
Number of rotatable bonds (#rotor)28
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)625.776
Computed dipole moment(dipole)5.562
Total solvent accessible surface area (SASA)1206.91
Hydrophobic component of SASA (FOSA)652.118
Hydrophilic component of SASA (FISA)473.936
Pie component of the SASA (PISA)65.227
Weakly polar component of the SASA (WPSA)15.632
Total solvent accesible volume (volume)2133.8
Number of hydrogen bond donors (donorHB)6.5
Number of hydrogen bond acceptors (accptHB)12.7
Free energy of solvation of dipole (dip^2/V)0.0144976
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0268277
Globularity descriptor (glob)0.664138
Predicted polarizability in cubic angstroms (QPpolrz)61.885
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.368
Predicted octanol/gas partition coefficient (QPlogPoct)37.372
Predicted water/gas partition coefficient (QPlogPw)26.299
Predicted octanol/water partition coefficient (QPlogPo/w)1.023
Predicted aqueous solubility (QPlogS)-5.608
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.072
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.167
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0
Predicted brain/blood partition coefficient (QPlogBB)-7.851
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.001
Predicted skin permeability, log Kp (QPlogKp)-9.399
PM3 calculated ionization potential (IP(ev))9.151
PM3 calculated electron affinity (EA(eV))1.068
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)-0.938
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)56.08
Van der Waals surface area (PSA)267.813
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P08514ITGA2BIntegrin alpha-IIb/beta-3T50688SEA
O00519FAAHAnandamide amidohydrolaseT11754SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
P09211GSTP1Glutathione S-transferase PiT21669SEA
P08263GSTA1Glutathione S-transferase A1T17221SEA
P04439HLA-AHLA class I histocompatibility antigen A-3T08985SEA
Q8TDS5OXER1Oxoeicosanoid receptor 1T68834SEA
Q16549PCSK7Subtilisin/kexin type 7T33211SEA
Q04760GLO1Glyoxalase IT88285SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
P09210GSTA2Glutathione S-transferase A2T53510SEA
P29120PCSK1Neuroendocrine convertase 1T36445SEA
Q92824PCSK5Proprotein convertase subtilisin/kexin type 5T38581SEA
Q9Y4G9PCSK6Proprotein convertase subtilisin/kexin type 6T86503SEA
O60603TLR2Toll-like receptor 2T82078SEA
Q92887CMOATMultidrug resistance-associated protein 2T61792SEA
Q92959SLCO2A1Prostaglandin transporterT15518SEA
P16519PCSK2Neuroendocrine convertase 2T97749SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T50688DI0007Acquired hypermelanosis[ICD-11: ED60]P08514ITGA2B
T50688DI0030Angina pectoris[ICD-11: BA40]P08514ITGA2B
T50688DI0287Myocardial infarction[ICD-11: BA41-BA43]P08514ITGA2B
T11754DI0101Corneal disease[ICD-11: 9A76-9A78]O00519FAAH
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T21669DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P09211GSTP1
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1
T82078DI0346Prostate cancer[ICD-11: 2C82]O60603TLR2

Copyright © 2025